• Wiley Online Library will be disrupted on 26 May from 10:00-12:00 BST (05:00-07:00 EDT) for essential maintenance

Chapter 12. Cytoskeletal Defects in Amyotrophic Lateral Sclerosis (Motor Neuron Disease)

  1. Derek J. Chadwick Organizer,
  2. Jamie Goode
  1. Jean-Pierre Julien,
  2. Stephanie Millecamps,
  3. Jasna Kriz

Published Online: 7 OCT 2008

DOI: 10.1002/0470093765.ch12

Nuclear Organization in Development and Disease: Novartis Foundation Symposium 264

Nuclear Organization in Development and Disease: Novartis Foundation Symposium 264

How to Cite

Julien, J.-P., Millecamps, S. and Kriz, J. (2008) Cytoskeletal Defects in Amyotrophic Lateral Sclerosis (Motor Neuron Disease), in Nuclear Organization in Development and Disease: Novartis Foundation Symposium 264 (eds D. J. Chadwick and J. Goode), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/0470093765.ch12

Author Information

  1. Research Center of CHUL and Department of Anatomy and Physiology of Laval University, 2705 Boulevard Laurier, Quebec, QC, G1V 4G2, Canada

Publication History

  1. Published Online: 7 OCT 2008
  2. Published Print: 14 JAN 2005

Book Series:

  1. Novartis Foundation Symposia

Book Series Editors:

  1. Novartis Foundation

ISBN Information

Print ISBN: 9780470093733

Online ISBN: 9780470093764

SEARCH

Keywords:

  • amyotrophic lateral sclerosis (ALS);
  • gene knockout approach;
  • Alsin gene mutations;
  • guanine nucleotide exchange factor (GEF);
  • motor neuron disease;
  • selective motor neuron degeneration;
  • cytoskeletal defects;
  • primary lateral sclerosis (PLS);
  • frameshift deletions in ALS2 gene coding

Summary

There is growing evidence for the involvement of cytoskeletal defects in the pathogenesis of motor neuron disease and especially in components of the microtubulebased transport system. Here we will review our recent work aiming to elucidate the role of peripherin in amyotrophic lateral sclerosis (ALS) and to address the mechanism of disease caused by deletions in the ALS2 gene that cause recessive forms of juvenile ALS and primary lateral sclerosis (PLS). Peripherin is an intermediate filament protein detected in spheroids, a hallmark of ALS, and increased levels of peripherin mRNA have been found in some ALS cases. Our transgenic mouse and cell culture studies support the view of a peripherin involvement in ALS. However, a gene knockout approach demonstrated that peripherin is not a key contributor of motor neuron disease caused by mutant superoxide dismutase linked to familial ALS. A recent breakthrough in the field of ALS came with the discovery of frameshift deletions in the ALS2 gene coding for Alsin. Our transfection experiments in cultured cells suggest that Alsin is a cytoskeletal protein with dual endosomal and centrosomal localizations. We have generated a mouse knockout for Alsin that develops progressive motor dysfunction during ageing. Thus, it is anticipated that this mouse model will be useful to investigate the pathogenic pathways linked to Alsin gene mutations.